These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29620655)

  • 1. Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.
    Kim YM; Kang E; Choi JH; Kim GH; Yoo HW; Lee BH
    Medicine (Baltimore); 2018 Apr; 97(14):e0309. PubMed ID: 29620655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
    Yuldashev AJ; Shin CH; Kim YS; Jang WY; Park MS; Chae JH; Yoo WJ; Choi IH; Kim OH; Cho TJ
    Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camurati-Engelmann Disease.
    Van Hul W; Boudin E; Vanhoenacker FM; Mortier G
    Calcif Tissue Int; 2019 May; 104(5):554-560. PubMed ID: 30721323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.
    Park SJ; Yoon CS; Park HW; Choi JR; Chung JS; Lee KA
    J Korean Med Sci; 2009 Aug; 24(4):737-40. PubMed ID: 19654961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the Natural History of Camurati-Engelmann Disease.
    Hughes P; Hassan I; Que L; Mead P; Lee JH; Love DR; Prosser DO; Cundy T
    J Bone Miner Res; 2019 May; 34(5):875-882. PubMed ID: 30690794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation.
    Simsek-Kiper PO; Dikoglu E; Campos-Xavier B; Utine GE; Bonafe L; Unger S; Boduroglu K; Superti-Furga A
    Am J Med Genet A; 2014 Oct; 164A(10):2667-71. PubMed ID: 25099136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camurati-Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones.
    Nishimura G; Nishimura H; Tanaka Y; Makita Y; Ikegawa S; Ghadami M; Kinoshita A; Niikawa N
    Am J Med Genet; 2002 Jan; 107(1):5-11. PubMed ID: 11807860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati-Engelmann disease.
    Tao XH; Yang XG; Wang ZY; Xu Y; Lin XY; Xu T; Zhang ZL; Yue H
    Mol Genet Genomic Med; 2022 May; 10(5):e1922. PubMed ID: 35315241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease.
    Chen Y; Xie W; Hu F; Chen J; Zheng H; Zhou H; Ni B; Li W; Zhou J
    Mol Med Rep; 2017 Jan; 15(1):235-239. PubMed ID: 27959412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V; Taxel P
    Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β1 gene mutations and phenotypes in pediatric patients with Camurati‑Engelmann disease.
    Wang C; Zhang BH; Liu YJ; Hu YQ; He JW; Zhang ZL
    Mol Med Rep; 2013 May; 7(5):1695-9. PubMed ID: 23503840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands.
    Toumba M; Neocleous V; Shammas C; Anastasiadou V; Allgrove J; Phylactou LA; Skordis N
    J Pediatr Endocrinol Metab; 2013; 26(9-10):987-93. PubMed ID: 23729546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFB1, and review.
    Wallace SE; Lachman RS; Mekikian PB; Bui KK; Wilcox WR
    Am J Med Genet A; 2004 Sep; 129A(3):235-47. PubMed ID: 15326622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camurati-Engelmann disease: a case report from sub-Saharan Africa.
    Mwasamwaja AO; Mkwizu EW; Shao ER; Kalambo CF; Lyaruu I; Hamel BC
    Oxf Med Case Reports; 2018 Jul; 2018(7):omy036. PubMed ID: 30034812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling.
    Clybouw C; Desmyttere S; Bonduelle M; Piepsz A
    Genet Couns; 1994; 5(2):195-8. PubMed ID: 7917133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Camurati-Engelmann disease].
    Kinoshita A
    Nihon Rinsho; 2015 Dec; 73(12):2149-59. PubMed ID: 26666167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.
    Janssens K; Vanhoenacker F; Bonduelle M; Verbruggen L; Van Maldergem L; Ralston S; Guañabens N; Migone N; Wientroub S; Divizia MT; Bergmann C; Bennett C; Simsek S; Melançon S; Cundy T; Van Hul W
    J Med Genet; 2006 Jan; 43(1):1-11. PubMed ID: 15894597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proband and the Brother.
    B S; Kotha JP
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.
    Bondestam J; Mäyränpää MK; Ikegawa S; Marttinen E; Kröger H; Mäkitie O
    Clin Rheumatol; 2007 Oct; 26(10):1773-7. PubMed ID: 17206397
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.